Literature DB >> 6488670

Neonatal pulmonary hypertension: pathophysiology, classification, and etiology.

W M Gersony.   

Abstract

Pulmonary hypertension in the newborn infant has many potential causes, and multiple etiologies are common. In this article, the author outlines the basic principles in pathophysiology, classification, and etiology that should be well understood by those who care for neonates with disease processes in which pulmonary hypertension is an important feature.

Entities:  

Mesh：

Year:  1984        PMID： 6488670

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN： 0095-5108            Impact factor:   3.430


  10 in total

Review 1.  Sildenafil for pulmonary hypertension in neonates.

Authors:  Lauren E Kelly; Arne Ohlsson; Prakeshkumar S Shah
Journal:  Cochrane Database Syst Rev       Date:  2017-08-04

2.  Regression of a large congenital hepatic arteriovenous malformation.

Authors:  Hala Mounir Agha; Rania Zakaria; Fatma Alzahraa Mostafa; Hala Hamza
Journal:  Tex Heart Inst J       Date:  2015-04-01

3.  Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome.

Authors:  J R Skinner; S Hunter; E N Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

4.  Acute pulmonary hypertension complicating the arterial switch procedure.

Authors:  J Freeman; S Y DeLeon; R H Miles; F X Downey; J Hofstra; J A Quinones; E A Fisher; R Pifarre
Journal:  Pediatr Cardiol       Date:  1995 Nov-Dec       Impact factor: 1.655

5.  Pulmonary and systemic arterial pressure in hyaline membrane disease.

Authors:  J R Skinner; R J Boys; S Hunter; E N Hey
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

Review 6.  Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.

Authors:  Enrique M Ostrea; Esterlita T Villanueva-Uy; Girija Natarajan; Herbert G Uy
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 7.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

8.  Effect of blood pressure cuffs on neonatal circulation: their potential application to newborns with persistent pulmonary hypertension.

Authors:  J Rhodes; J T Wung; F Z Bierman
Journal:  Pediatr Cardiol       Date:  1995 Jan-Feb       Impact factor: 1.655

9.  Morphometric analysis of the lung vasculature after extracorporeal membrane oxygenation treatment for pulmonary hypertension in newborns.

Authors:  Arno van Heijst; Remco Haasdijk; Freek Groenman; Frans van der Staak; Christina Hulsbergen-van de Kaa; Ronald de Krijger; Dick Tibboel
Journal:  Virchows Arch       Date:  2004-06-03       Impact factor: 4.064

10.  Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.

Authors:  Marc Chester; Pierre Tourneux; Greg Seedorf; Theresa R Grover; Jason Gien; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.